Residual disease after a neoadjuvant therapy: a strong prognostic and potentially predictive biomarker to personalize therapy

被引：0
|
作者：
Krop, I. [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
BREAST | 2021年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SA 9.3
引用
收藏
页码：S13 / S14
页数：2
相关论文
共 50 条
  • [1] Biomarkers of residual disease after neoadjuvant therapy for breast cancer
    Penault-Llorca, Frederique
    Radosevic-Robin, Nina
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2016, 13 (08) : 487 - 503
  • [2] Biomarkers of residual disease after neoadjuvant therapy for breast cancer
    Frederique Penault-Llorca
    Nina Radosevic-Robin
    [J]. Nature Reviews Clinical Oncology, 2016, 13 : 487 - 503
  • [3] Prognostic significance of a modified residual disease in breast and nodes (mRDBN) algorithm after neoadjuvant therapy for breast cancer
    Farrugia, D. J.
    Landmann, A.
    McAuliffe, P. F.
    Diego, E. J.
    Johnson, R.
    Bonaventura, M.
    Soran, A.
    Dabbs, D. J.
    Clark, B.
    Lembersky, B. C.
    Puhalla, S. L.
    Brufsky, A.
    Jankowitz, R.
    Davidson, N. E.
    Ahrendt, G. M.
    Bhargava, R.
    [J]. CANCER RESEARCH, 2017, 77
  • [4] ER pathway activity as a predictive biomarker for neoadjuvant endocrine therapy
    Blok, E. J.
    de Inda, M. Alves
    Charehbili, A.
    den Biezen, E.
    Fruytier, S.
    van Brussel, A.
    Seynaeve, C. M.
    Kroep, J. R.
    Verhaegh, W.
    van de Velde, C. J. H.
    van de Stolpe, A.
    Kuppen, P. J. K.
    [J]. CANCER RESEARCH, 2016, 76
  • [5] Prognostic impact of intraoperative peritoneal cytology after neoadjuvant therapy for potentially resectable pancreatic cancer
    Aoki, Shuichi
    Mizuma, Masamichi
    Hayashi, Hiroki
    Yoshimachi, Shingo
    Hata, Tatsuo
    Miura, Takayuki
    Takadate, Tatsuyuki
    Maeda, Shimpei
    Ariake, Kyohei
    Kawaguchi, Kei
    Masuda, Kunihiro
    Ishida, Masaharu
    Ohtsuka, Hideo
    Nakagawa, Kei
    Morikawa, Takanori
    Motoi, Fuyuhiko
    Unno, Michiaki
    [J]. PANCREATOLOGY, 2020, 20 (08) : 1711 - 1717
  • [6] Prognostic and Predictive Value of an Immunopathomics Signature in Rectal Cancer Patients after Neoadjuvant Therapy
    Dong, Xiaoyu
    Jiang, Wei
    Chen, Dexin
    Yan, Botao
    Wang, Ting
    Cheng, Jiaxin
    Tang, Yuting
    Zheng, Jixiang
    Chen, Zhenbang
    Yan, Jun
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2023, 237 (05) : S88 - S88
  • [7] Residual Disease after Neoadjuvant Therapy for Breast Cancer: Can MRI Help?
    Hylton, Nola M.
    [J]. RADIOLOGY, 2018, 289 (02) : 335 - 336
  • [8] Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer A Review
    Tarantino, Paolo
    Hortobagyi, Gabriel
    Tolaney, Sara M.
    Mittendorf, Elizabeth A.
    [J]. JAMA ONCOLOGY, 2024,
  • [9] Prognostic significance of residual nodal disease after neoadjuvant endocrine therapy for hormone receptor-positive breast cancer
    Kantor, Olga
    Wong, Stephanie
    Weiss, Anna
    Metzger, Otto
    Mittendorf, Elizabeth A.
    King, Tari A.
    [J]. NPJ BREAST CANCER, 2020, 6 (01)
  • [10] Prognostic significance of residual nodal disease after neoadjuvant endocrine therapy for hormone receptor-positive breast cancer
    Olga Kantor
    Stephanie Wong
    Anna Weiss
    Otto Metzger
    Elizabeth A. Mittendorf
    Tari A. King
    [J]. npj Breast Cancer, 6
12345